PALO ALTO, Calif. - (Business Wire) Affymax, Inc. (Nasdaq:AFFY) today announced that Arlene Morris, the company
’s president and chief executive officer, will present at the following investor conferences in April and May.
| Morgan Stanley Global Healthcare Unplugged Conference |
| The Ritz-Carlton, Key Biscayne, Fla. |
| Wednesday, April 30, 2008 |
| 11:10 a.m. ET |
| |
| 2008 Citi Investment Research Global Health Care Conference |
| Hilton New York Hotel |
| Wednesday, May 21, 2008 |
| 10:00 a.m. ET |
A live webcast of the presentations will be available on the investors section of the company’s website at www.affymax.com. A replay will also be available for 30 days following the presentations.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax’s lead product candidate, Hematide™, is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure and in a Phase 1 clinical trial for the treatment of anemia in cancer patients. For additional information, please visit www.affymax.com.
Affymax, Inc.
Sylvia Wheeler, 650-812-8861
Executive Director, Corporate Communications
